UK life sciences: Catalysing investment and growth

This report sets out how the UK life sciences sector is driving investment and growth and makes the case for increased cost-effective public investment in the sector. The report aims to inform the Government, UK Research and Innovation (UKRI), and other policymakers as they prepare for the forthcoming Spending Review and develop an R&D roadmap to reach the target of raising R&D investment to 2.4% of GDP by 2027.

More within